U.S. employers are more focused on social distancing, clean workspaces and allowing workers to work from home than testing for Covid-19 antibodies, big purchasers of healthcare say.
Healthcare organizations relied on data and AI even before COVID-19, but it is critical during the pandemic to help forecast demand, ICU capacity, and even a second wave of the virus.
The U.S. Food and Drug Administration said Abbott Laboratories widely used test to detect the Coronavirus strain Covid-19 “may return false negative results.”
U.S. employers aren’t sold on Coronavirus antibody tests for their workers as the country prepares to re-open for business amid the COVID-19 pandemic, a Mercer benefits survey showed.
Abbott Laboratories antibody test for the Coronavirus strain COVID-19 “demonstrates excellent analytical performance,” researchers from the University of Washington wrote in the Journal of Clinical Microbiology.
CVS Health reported a 600% surge in use of its retail health clinics via telehealth and a 1,000% jump in home prescription delivery as Americans sought quick access to health services amid Coronavirus pandemic.
New research by Harvard Business Review Analytic Services, sponsored by ThoughtSpot, reveals that companies that give employees the freedom and tools to make data-driven decisions outperform those that don’t. Here we dive into the details and explore w…